News Search Results
Jun 12, 2025, 11:55 ET LabConnect Selects Deloitte to Streamline Financial and Business Operations
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jun 12, 2025, 11:50 ET Formwork System Market Size is Expected to Grow at 5.53% CAGR with US$ 9.32 Billion by 2031, Driven by Experiences Growing Number of Infrastructure Projects Globally | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 12, 2025, 11:45 ET LabConnect Selects Deloitte to Streamline Financial and Business Operations
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jun 12, 2025, 11:15 ET Fiber Optic Sensor Market Size Reach US$ 6.76 Billion by 2031, Experiences Growth Owing to Rising demand for Structural Health Monitoring | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 12, 2025, 11:00 ET EV Connector Market Size to Surge to USD 12.39 Billion by 2031, Driven by 25.3% CAGR | Experiences Growth Owing to Growing EV Industry
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 12, 2025, 10:29 ET Medical Waste Management Market worth US$59.42 billion by 2030 with 8.0% CAGR | Exclusive Study by The Research Insights
to US$ 59.42 billion by 2030, the Global Medical Waste Management Market represents a significant opportunity for biotechnology firms, recycling technology developers, start-ups focused on eco-friendly disposal solutions, private equity investors, and logistics and transportation
More news about: The Research Insights
Jun 12, 2025, 10:05 ET T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
in health care innovations. The fund's portfolio typically consists of 100 to 150 stocks and is diversified across health care, with a focus on biotechnology, pharmaceuticals, products and device providers, and health care service companies. TMED will be co-managed by Sal Rais,
More news about: T. Rowe Price Group
Jun 12, 2025, 10:00 ET Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
CITY, June 12, 2025 /PRNewswire/ -- Rebel Medicine Inc, a clinical‑stage biotechnology company developing innovative drug delivery systems and non‑opioid pain therapeutics for acute and post-operative pain, announced the closing of
More news about: Rebel Medicine Inc
Jun 12, 2025, 09:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jun 12, 2025, 09:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jun 12, 2025, 08:47 ET NovoLINC Appoints Tech Industry Veteran Bob Wenner as COO to Scale Product for AI Data Center Cooling
M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. M Ventures covers the areas of Healthcare drug development, Life Science tools, Electronics and Frontier Technology & Sustainability.
More news about: NovoLINC, Inc.
Jun 12, 2025, 08:33 ET GlycoNex Announces Publication of Preclinical Study on GNX1021, a Novel Glycan-Targeted ADC for Gastric Cancer
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical-stage biotechnology company specializing in glycan-directed cancer immunotherapies, today announced that its first-in-class antibody-drug conjugate (ADC), GNX1021,
More news about: GlycoNex, Inc.
Jun 12, 2025, 08:03 ET Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases
Mass., June 12, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced a license agreement with Visterra,
More news about: Nona Biosciences
Jun 12, 2025, 08:02 ET Lafayette Square Provides Financing to Support Ickler Electric's ESOP
Founded in 1985, Ickler Electric specializes in highly technical, mission-critical projects across biotechnology and life sciences, pharmaceutical, laboratory and other commercial industries. Ickler has a robust set of capabilities, including extensive in-house
More news about: Lafayette Square Holding Company
Jun 12, 2025, 08:00 ET Ouro Medicines Announces a Clinical Trial of OM336 for Autoimmune Cytopenias Following Positive Case Reports in The New England Journal of Medicine
SAN FRANCISCO, June 12, 2025 /PRNewswire/ -- Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced plans to initiate a multi-national
More news about: Ouro Medicines
Jun 12, 2025, 08:00 ET Arthrosi Presents Positive Long-Term Safety and Efficacy Data for Pozdeutinurad (AR882) at the European Alliance of Associations for Rheumatology (EULAR) Congress 2025
DIEGO, June 12, 2025 /PRNewswire/ -- Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels,
More news about: Arthrosi Therapeutics
Jun 12, 2025, 07:00 ET Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
researchers and therapeutic developers to continue to drive successful patient outcomes. About SynthegoSynthego is a leader in biotechnology, dedicated to delivering best-in-class CRISPR solutions with a mission to accelerate research and development in the pursuit of improved human health.
More news about: Synthego
Jun 12, 2025, 06:30 ET ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
B-cell malignancies and earlier lines of therapy. About ADC Therapeutics ADC Therapeutics (NYSE: ADCT) is a commercial-stage biotechnology company helping to improve the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates (ADCs). The Company
More news about: ADC Therapeutics SA
Jun 12, 2025, 05:00 ET Industrial Enzymes Market worth $12.01 billion by 2030- Exclusive Report by MarketsandMarkets™
environmental concerns have prompted industries to adopt enzyme-based solutions for water treatment and pollution control. Government support for biotechnology and bioeconomy development, such as India's BioE3 policy launched in August 2024,
More news about: MarketsandMarkets
Jun 12, 2025, 03:32 ET Aquaporin appoints Chief Executive Officer
Directors of Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, is delighted to announce the appointment of Ulrik Lund Jakobsen as the new Chief Executive Officer of Aquaporin
More news about: Aquaporin A/S
Jun 12, 2025, 03:22 ET Aquaporin appoints Chief Executive Officer
Directors of Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, is delighted to announce the appointment of Ulrik Lund Jakobsen as the new Chief Executive Officer of Aquaporin
More news about: Aquaporin A/S
Jun 12, 2025, 02:00 ET Fortune Unveils First-Ever Europe's Most Innovative Companies List
personalization tools and biological skin age technology to generate custom skincare recommendations. Unilever is second for pioneering work in biotechnology and its new AI-assisted laundry detergent. "There's a misconception that Europe is not innovative," said
More news about: Fortune Media (USA) Corporation
Jun 12, 2025, 02:00 ET Real-world prospective data confirms improved risk stratification in multiple myeloma using SKY92 gene expression profiling
(LDT) from SkylineDx's CAP/CLIA lab in San Diego (CA, USA). About SkylineDx SkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, inflammatory, and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Jun 12, 2025, 01:44 ET Shareholder Alert: Robbins LLP Informs Investors of the Rocket Pharmaceuticals, Inc. Class Action
between February 7, 2025 and May 26, 2025. Rocket is a fully integrated, late-stage biotechnology company focused on the development of gene therapies, with direct on-target mechanism of action and clear clinical endpoints, for rare and devastating
More news about: Robbins LLP
Jun 11, 2025, 23:46 ET Intensity Therapeutics, Inc. Announces Pricing of Public Offering
June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase
More news about: Intensity Therapeutics Inc.